G
o
o
g
l
e
×
Please click
here
if you are not redirected within a few seconds.
All
Shopping
Images
News
Maps
Videos
Books
Search tools
Past year
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Clear
Vertex non-opioid painkiller meets main goal in late-stage trials
Reuters
Vertex Pharmaceuticals' experimental drug reduced acute, post-surgical pain without the risk of addiction, a major milestone in the company's decades-long...
10 months ago
LSU Health New Orleans Researchers Develop New Painkiller that Promises Safer, Non-Addictive Relief
LSU
Researchers have developed a novel, non-addictive, non-toxic painkiller that offers the hope of pain relief while also addressing the opioid crisis.
6 months ago
New Painkiller Could Bring Relief to Millions—Without Addiction Risk
Scientific American
The medication initially known as VX-548 blocks sodium channels in nerves, blocking pain signals before they reach the brain.
3 months ago
New Non-Opioid Pain Meds Hold Promise, But Face Clinical Development And Insurer Challenges
Forbes
While there's a need for novel non-opioid drugs for pain, they face clinical development and reimbursement challenges.
8 months ago
No pain some commercial gain: Non-Addictive Prescription Medicines
IQVIA
Non-addictive pain medications offer hope to alleviate the disease burden associated with pain. Acute pain is unwelcome and burdensome.
6 months ago
Vertex Experimental Drug Cuts Off Pain at the Source, Company Says
The New York Times
Vertex Pharmaceuticals said its medicine could address moderate to severe acute pain, and might be able to avoid the risk of addiction.
10 months ago
Vertex Pharma scientist talks about the long road to developing non-addictive painkillers
AP News
Patients suffering from pain have limited options when it comes to medication. For decades, the only two choices have been over-the-counter medicines like...
7 months ago
SRP-001: redefining pain treatment with a safer, non-opioid analgesic
Drug Target Review
This Q&A with Dr Hernan A Bazan, CEO and Co-founder of South Rampart Pharma, Inc, discusses the potential merits of novel non-opioid analgesic SPR-001.
5 months ago
Voices for Non-Opioid Choices Coalition Applauds Introduction of Alternatives to PAIN Act in Senate
PR Newswire
The Alternatives to PAIN Act will ensure that all Americans can access safe, effective, non-addictive pain management approaches.
9 months ago
Experimental Pain Medication May Relieve Acute Pain Without Risk of Addiction, Study Finds
Verywell Health
Vertex Pharmaceuticals shared the late-stage study results of its experimental painkiller for acute moderate to severe pain. The drug could give patients a...
10 months ago